We are live on
!
Find out more
CW
Cabot-Wellington Portfolio holdings
AUM
$380M
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+1.89%
1 Year Est. Return
+21.78%
3 Year Est. Return
+64.98%
5 Year Est. Return
+59.32%
10 Year Est. Return
+170.75%
AUM
$146M
AUM Growth
+$10.3M
(+7.6%)
Cap. Flow
+$8.1M
Cap. Flow
% of AUM
5.55%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
2
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$4.15M |
| 2 |
AbbVie
ABBV
|
+$3.91M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cabot Corp
CBT
|
+$541K |
| 2 |
CTRA
Coterra Energy
CTRA
|
+$492K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 14.58% |
| 2 | Energy | 13.07% |
| 3 | Healthcare | 3.05% |
| 4 | Industrials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
| $62.6M | 42.87% |
446,076
+29,775
| +7% | +$4.15M |
|
|
2
iShares Core MSCI EAFE ETF
IEFA
$190B
| $37.8M | 25.86% |
596,377
+16,262
| +3% | +$1.08M |
|
|
3
Cabot Corp
CBT
$4.54B
| $21.3M | 14.58% |
344,865
-9,147
| -3% | -$541K |
|
|
CTRA
4
DELISTED
Coterra Energy
CTRA
| $19.1M | 13.07% |
802,237
-21,099
| -3% | -$492K |
|
|
5
AbbVie
ABBV
$446B
| $3.71M | 2.54% |
+40,000
| New | +$3.91M |
|
6
Johnson & Johnson
JNJ
$621B
| $418K | 0.29% |
3,450
| – | – |
|
7
Pfizer
PFE
$143B
| $326K | 0.22% |
9,486
| – | – |
|
8
FedEx
FDX
$73B
| $296K | 0.2% |
1,300
| – | – |
|
9
Honeywell
HON
$77.5B
| $279K | 0.19% |
2,148
| – | – |
|
10
3M
MMM
$90.8B
| $264K | 0.18% |
1,615
| – | – |
|
Similar funds
AC
EAM
MC
NICM
KFS
CFG
PIM
AWA
Cabot-Wellington's Q2 2018 Portfolio in Review
As of Q2 2018, Cabot-Wellington held 10 positions worth $146M, up 7.6% from $136M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Cabot-Wellington deployed $8.1M of net new capital in Q2 2018, opening 1 new position and adding to 2 existing holdings. Its largest new stake was AbbVie: 40,000 shares worth $3.71M.
By sector, the portfolio is most concentrated in Materials at 15% of assets, up from 15% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Cabot Corp, an estimated $541K trimmed.
- Cabot-Wellington's largest Q2 2018 buy was AbbVie: 40,000 shares worth $3.71M.
- Cabot-Wellington added most to Vanguard Morningstar Total Stock Market ETF in Q2 2018, an estimated $4.15M increase.
- Cabot-Wellington's biggest Q2 2018 reduction was Cabot Corp, cutting an estimated $541K.
- Cabot-Wellington's ten largest holdings make up 100% of its $146M portfolio in Q2 2018.
- Cabot-Wellington opened 1 new position and closed 0 in Q2 2018.
- Cabot-Wellington's portfolio value rose 7.6% quarter-over-quarter to $146M.
Based on Cabot-Wellington's 13F filing for Q2 2018, filed 13 Jul 2018.